Home Healthcare Cancer Tumor Profiling Market
cancer tumor profiling market

Cancer/Tumor Profiling Market Share, Size, Trends, Industry Analysis Report by Technology (Immunoassay, NGS, PCR, In Situ Hybridization, Microarray, Mass Spectrometry, Others); By Biomarker Type (Genomic Biomarkers, Protein Biomarkers, Others); By Cancer Type; By Application; By Regions - Segment Forecast, 2020 - 2027

  • Published Date: Sep 2020
  • Pages: 122
  • Format: PDF
  • Report ID: PM1713
  • Base Year: 2019
  • Historical Data: 2016-2018

Report Scope

Cancer Tumor/Profiling Technology Outlook (Revenue, USD Million, 2016 - 2027)

  • Immunoassay
  • NGS
  • PCR
  • In Situ Hybridization
  • Microarray
  • Mass Spectrometry
  • Others

Cancer Tumor/Profiling Cancer Type Outlook (Revenue, USD Billion, 2016 - 2027)

  • Breast
  • Lung
  • Colorectal
  • Prostate
  • Melanoma
  • Others

Cancer Tumor/Profiling Biomarker Type Outlook (Revenue, USD Billion, 2016 - 2027)

  • Genomic Biomarkers
  • Protein Biomarkers
  • Others

Cancer Tumor/Profiling Application Outlook (Revenue, USD Billion, 2016 - 2027)

  • Personalized Medicine
  • Diagnostics
  • Prognostics
  • Biomarker Discovery
  • Research

Cancer Tumor/Profiling Regional Outlook (Revenue, USD Million, 2016 - 2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
  • Asia Pacific
    • India
    • Japan
    • China
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Colombia
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Israel
    • UAE
Polaris Market Research
Cancer/Tumor Profiling Market Size | Global Industry Report, 2020-2027